Pulsed Electromagnetic Field Therapy (PEMT) in Patients With Degenerative Meniscus Lesions

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age35-65
SponsorAfyonkarahisar Health Sciences University

About this trial

Pulse Electromagnetic Field Therapy (PEMT) is effective in the treatment of many diseases, especially musculoskeletal system diseases, due to its analgesic effect with the effect of induced currents, and also its anti-inflammatory , edema reducing, antispasmodic and blood flow accelerating effects with additional mechanisms. The aim of our study is to evaluate the effects of Pulsed Electromagnetic Field Therapy (PEMT) degenerative To investigate the effects on pain, quality of life and function in patients with meniscal lesions.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Knee pain for at least 2 months

MRI findings of meniscus degeneration

The health condition is suitable for rehabilitation

Ability to understand commands

Disqualifiers

Inability to cooperate fully and lack of literacy skills

NSAID use

Planning pregnancy during pregnancy or treatment process

A history of physical therapy and rehabilitation for the knee area in the last 6 months.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Rehabilitation

    Other intervention

    As a therapeutic exercise program, it was planned to apply joint range of motion, walking, balance, coordination, cycling, isometric and isotonic strengthening exercises by a trained physiotherapist with at least 5 years of experience and that the patients would do these exercises three times a day, in 3 sets, with 10 repetitions.

Treatment groups

80 Participants
are divided into 2 treatment groups
Group A: PEMTExperimental treatment 1 intervention
Group B: SHAMSham comparator 1 intervention

Trial outcomes

Primary outcomes

1

Visual Pain Scale (VAS) - night - rest - movement

In treatments applied for knee pain, the primary goal is to focus on the restoration of pain and movement function. Visual Pain Scale (VAS), which is easy to understand, apply and interpret, and provides valid and reliable data in a short time, is the most commonly used method in clinics. With a 100 mm visual linear scale, the patient is told that there is no pain at 0, and that the most severe pain ever felt at 100, and the patient is asked to mark the point corresponding to rest, movement and night pain.

Time frame
Before treatment (T0) At the end of treatment (4 weeks) (T1) At 6 months (T2)
2

KOOS ( KNEE INJURY AND OSTEOARTHRITIS OUTCOME SCORE)

It is a scale used to evaluate symptoms and functional status related to knee injuries and knee osteoarthritis . It has 5 subgroups: pain, daily living activities (ADL), functional status in sports and leisure activities and quality of life related to the knee. Each question is scored with a total of 5 options between 0-4. The average score in each section is multiplied by 100, divided by 4 and subtracted from 100. The possible score varies between 0 and 100 points in each case. A score of 100 indicates no restrictions due to the affected knee , while a score of 0 indicates excessive problems and restrictions.

Time frame
Before treatment (T0) At the end of treatment (4 weeks) (T1) At 6 months (T2)
3

Lysholm Knee Scoring Scale

8 items are asked about symptoms and a total score (0-100) is calculated. A score of 0 indicates the lowest knee function, while a score of 100 indicates the highest knee function. There is a Turkish validity and reliability study.

Time frame
Before treatment (T0) At the end of treatment (4 weeks) (T1) At 6 months (T2)
4

Western Ontario Meniscus Assessment Questionnaire

Physical symptoms experienced by patients due to knee problems are questioned. A total of 16 questions in 3 sections are given 0-10 points. The score for each subgroup is obtained by dividing the marked values of the questions in that section by the number of questions and multiplying by 10. For the total score, all marked values are added, divided by 16 and multiplied by 10. The score is between 0-100. 0 indicates the best symptoms and function, while 100 indicates the worst symptoms and function. There is a Turkish validity and reliability study.

Time frame
Before treatment (T0) At the end of treatment (4 weeks) (T1) At 6 months (T2)

Secondary outcomes

1

Knee joint range of motion (ROM)

In measuring knee range of motion, flexion and extension movements are measured with a goniometer while the patient lies on his back, including active and passive measurements of the knee.

Time frame
Before treatment (T0) At the end of treatment (4 weeks) (T1) At 6 months (T2)
2

Tegner Activity Level Scale

This scale aims to evaluate the activity level of people with knee injuries. The patient's activity is scored between 0 and 10. 0 indicates the lowest activity level, while 10 indicates the highest activity level. There is a Turkish validity and reliability study.

Time frame
Before treatment (T0) At the end of treatment (4 weeks) (T1) At 6 months (T2)
3

Lower Extremity Y Dynamic Balance Test:

Balance is maintained on the Y dynamic balance test platform by keeping the hands fixed on the waist area and the foot fixed at the center point. Then, while maintaining the fixed stance with one foot, the blocks are pushed with the toe tip with the other foot in the anterior (0°), posteromedial (45°) and posterolateral (45°) directions (each time bringing the foot back to the fixed stance point without touching the ground) . After the test is repeated 3 times in each of the three directions ( anterior , posteromedial , posterolateral ), the normalization formula is used. The sum of the 3 directions is divided by 3 times the leg length and multiplied by 100.

Time frame
Before treatment (T0) At the end of treatment (4 weeks) (T1) At 6 months (T2)
4

SF -36

SF -36 is a generic quality of life scale. It provides the opportunity to ev.aluate the health status of the person in 10 sub-parameters such as physical function, body pain, limitation due to physical problems, emotional well-being, social function, energy/fatigue, general health perception. It contains a total of 36 items. It is evaluated between 0-100 points. It was created to evaluate the health status.

Time frame
Before treatment (T0) At the end of treatment (4 weeks) (T1) At 6 months (T2)

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: